Legend Biotech (LEGN) Tops Q3 EPS by 14c

Legend Biotech (NASDAQ: LEGN) reported Q3 EPS of ($0.17), $0.14 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $96.01 million versus the consensus estimate of $97.42 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
• Nike names former Pfizer CFO David Denton as new finance chief